PATENT CLAIM ANALYSIS

Application Number: 15903379
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["514", "021300"]

Abstract:
The present invention provides a peptide at least partially derivable from human Thyroid Stimulating Hormone Receptor (TSHR) which peptide is capable of binding to an MHC molecule in vitro and being presented to a T cell without further antigen processing. The present invention also relates to the use of such peptides for the prevention or suppression of activating autoantibody formation in Graves' Disease.

Claim (Index 14):
A method for suppressing or preventing the production of TSHR autoantibodies in a subject, which comprises the step of administration of a peptide according to  claim 1  to the subject.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 88.0
- Lexical Diversity: 1.21429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14910372', '15537577', '13320201', '13706540', '11979224']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7843716032645123
- 35 USC 102 Novelty (BERT): 0.6269133039634747
- Combined Prediction Score: 0.7686257733344085
- Mean Citation Score: 359.11758
- Max Citation Score: 627.2011
- Similarity Product: 514.7136178657413

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test